Clinical Trials Sponsored by Oswaldo Cruz Institute

Total 135 results

Oswaldo Cruz Foundation

Unknown

Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis (Prospec-HIV)

Liver Diseases | Fibrosis | Liver Cirrhosis | Human Immunodeficiency Virus | Acquired Immune Deficiency Syndrome Virus

Brazil
Oswaldo Cruz Foundation

Unknown

Implementation of PrEP to HIV in Brazilian Transgender Women (PrEParadas)

HIV, Prevention

Brazil
Oswaldo Cruz Foundation

Completed

Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion

Cervical Intraepithelial Neoplasia

Brazil
Oswaldo Cruz Foundation

Recruiting

Anti-Schistosomiasis Sm14-vaccine in Senegal

Vaccination; Infection | Schistosomiasis Mansoni | Schistosomiasis Haematobium

Senegal
Oswaldo Cruz Foundation

Recruiting

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals (YF-HIV)

HIV Infections

Brazil
Oswaldo Cruz Foundation

Unknown

Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children

Yellow Fever

Brazil
Oswaldo Cruz Foundation

Completed

A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins

Cervical Intraepithelial Neoplasia

Brazil
Oswaldo Cruz Foundation

Recruiting

GastrOesophageal Varices After Sustained Virological Response (GOVaSViR)

Liver Diseases | Hepatitis C

Brazil
Oswaldo Cruz Foundation

Unknown

Growth and Body Composition in Preterm Infants (Crescer)

Body Composition

Brazil
Oswaldo Cruz Foundation

Unknown

HIV Self-testing in Implementation PrEP Study

HIV Prevention
Oswaldo Cruz Foundation

Completed

Clinical Protocol Validation to Identify Prognostic Markers for Critical Care Pediatric Patients (PCL07)

Sepsis

Brazil
Oswaldo Cruz Foundation

Completed

A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers

Tuberculosis

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Not yet recruiting

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients

Leprosy

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Completed

Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella (BIOMR)

Measles | Rubella

Brazil
Hospital Alemão Oswaldo Cruz

Recruiting

Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait (CCHOWW)

Rectal Cancer | Consolidation

Brazil, Argentina, Uruguay
Hospital Alemão Oswaldo Cruz

Recruiting

Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease (OBESE-DKD)

Diabetes Mellitus, Type 2 | Kidney Injury | Kidney Disease, Chronic

Brazil
Oswaldo Cruz Foundation
Abbott

Completed

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin (A06-295)

HIV Infection | Tuberculosis

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Foundation

Recruiting

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Guillain-Barre Syndrome | Transverse Myelitis | Acute Disseminated Encephalomyelitis | Vaccine-induced Thrombotic Thrombocytopenia Syndrome

Brazil
Oswaldo Cruz Foundation
Instituto Fernandes Figueira

Completed

Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

Hyperbilirubinemia | Erythroblastosis, Fetal

Brazil
Oswaldo Cruz Foundation
PAPES/Fiocruz

Completed

Energy Expenditure Assessment of Premature Infants

Weight

Brazil
University of Miami
Oswaldo Cruz Foundation

Terminated

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Tuberculosis | AIDS

Brazil
Oswaldo Cruz Foundation
Montefiore Medical Center

Unknown

Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity (quarenta)

Pregnancy

Brazil
Oswaldo Cruz Foundation
Ministry of Health, Brazil

Terminated

Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity

Sepsis | Premature Birth | Bronchopulmonary Dysplasia | Bacterial Vaginosis | Periventricular Leukomalacia

Brazil
Oswaldo Cruz Foundation
University of Sao Paulo

Active, not recruiting

Transmission Dynamics of Residual and Re-emerging Malaria in the Amazon: Defining a Roadmap to Malaria Elimination

Malaria

Brazil
Oswaldo Cruz Foundation
Ministry of Health, Brazil

Completed

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults (VIP-H1N1)

HIV Infection

Brazil
Oswaldo Cruz Foundation
World Health Organization; UNITAID

Not yet recruiting

Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro

Hepatitis C

Brazil
Centre Hospitalier de Cayenne
Oswaldo Cruz Foundation

Recruiting

Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield (CUREMA)

Malaria, Vivax

Brazil, Suriname
Oswaldo Cruz Foundation
Hospital Universitario Pedro Ernesto

Completed

Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment (ADELES)

Systemic Lupus Erythematosus | Medication Adherence

Brazil
Oswaldo Cruz Foundation
University of Sao Paulo

Completed

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection

Malaria, Vivax

Brazil
Federal University of Bahia
Oswaldo Cruz Foundation

Unknown

Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease

Sickle Cell Disease | Chronic Leg Ulcer
Oswaldo Cruz Foundation
Ministry of Health, Brazil

Terminated

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg (IPEC-EFV)

HIV Infections | Tuberculosis

Brazil
Oswaldo Cruz Foundation
Ministry of Health, Brazil

Completed

Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy

HIV Infections | Pregnancy

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed

Measles

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Unknown

Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa

Renal Insufficiency, Chronic | Red-Cell Aplasia, Pure
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Meningitis, Meningococcal, Serogroup C

Brazil
Hospital Alemão Oswaldo Cruz
Ministry of Health, Brazil

Recruiting

Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil

Healthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated Infection

Brazil
Rio de Janeiro State University
Oswaldo Cruz Foundation

Completed

Nudging, Healthy Diet and Physical Activity

Obesity

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Active, not recruiting

Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.

COVID-19

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military

Yellow Fever Vaccine

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers

Chronic Viral Hepatitis C

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

Measles | Rubella | Mumps

Brazil
Hospital Universitário Professor Edgard Santos
Oswaldo Cruz Foundation

Completed

Miltefosine and GM-CSF in Cutaneous Leishmaniasis

Cutaneous Leishmaniasis

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Not yet recruiting

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Measles Vaccine
The Immunobiological Technology Institute (Bio-Manguinhos)...

Recruiting

Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine

COVID-19

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Active, not recruiting

Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control Study

COVID-19 Vaccines

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Active, not recruiting

Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.

Foot Ulcer, Diabetic | Epidermal Growth Factor
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) Screening

Mass Screening

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Unknown

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Serogroup C Meningococcal Meningitis

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations (MMR)

Measles | Rubella | Mumps

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Immunity After Two Doses of Yellow Fever Vaccine (IATDYFV)

Yellow Fever

Brazil

Clinical Trials Sponsored by Oswaldo Cruz Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations